Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma

Physical function is a predictive and prognostic marker that complements ECOG-PS, supporting its use in informing therapy decisions for daratumumab-based treatments.

Authors

Institutions

Publication Details

Journal
European Journal Of Haematology
Published
2025-03-14
DOI
https://doi.org/10.1111/ejh.14410
Citations
1
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma

Mohammad H. Semreen, Humaid Obaid Al-Shamsi, Ganessan Kichenadasse, Sara A. Almansour et al.
1 citations
European Journal Of Haematology
Multiple Myeloma Research and Treatments
1.77
article

Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma

Mohammad H. Semreen, Humaid Obaid Al-Shamsi, Ganessan Kichenadasse, Sara A. Almansour, Yasser Bustanji, Ross A. McKinnon, Rawan Mohamed, Ashley M. Hopkins, Michael J. Sorich, Ziad Abuhelwa, Karem H. Alzoubi, Zelal Jaber Kharaba, Ethan Basch, Ahmad Y. Abuhelwa, Salma M. Ali
article en
1 citations

Abstract

Physical function is a predictive and prognostic marker that complements ECOG-PS, supporting its use in informing therapy decisions for daratumumab-based treatments.

European Journal Of HaematologyVol. 114(6)
University of North Carolina at Chapel Hill (US), University of Jordan (JO), Jordan University of Science and Technology (JO), Flinders University (AU), University of South Florida (US), Cancer Institute (WIA) (IN), Kuwait Cancer Control Center (KW), University of Sharjah (AE), Moffitt Cancer Center (US), UNC Lineberger Comprehensive Cancer Center, Ras al-Khaimah Medical and Health Sciences University (AE)
Tour de Cure
Good health and well-being
Openalex Percentile: Top 18%
Multiple Myeloma Research and Treatments
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Predictive and Prognostic Significance of Patient‐Reported Outcomes for Survival and Adverse Events in Daratumumab‐Treated Multiple Myeloma — Mohammad H. Semreen, Humaid Obaid Al-Shamsi, et al. · European Journal Of Haematology (2025) | TGRS Research Map | TGRS